Skip to main content


Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Individualised treatment targets in patients with type-2 diabetes and hypertension

Fig. 2

a Proportions of patients meeting treatment targets at 12 months, stratified by baseline HbA1c tertile and target type. b Change in HbA1c at 12-month follow-up by baseline HbA1c and treatment target group. Only patients with valid baseline and 12 month follow-ups including complete information on HbA1c levels were included. Percentages refer to the proportion of patients within the specific subgroup represented by each column

Back to article page